Agenus Inc Stock Performance
| AGEN Stock | USD 3.06 0.15 4.67% |
The firm shows a Beta (market volatility) of 0.73, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Agenus' returns are expected to increase less than the market. However, during the bear market, the loss of holding Agenus is expected to be smaller as well. At this point, Agenus Inc has a negative expected return of -0.43%. Please make sure to confirm Agenus' jensen alpha, accumulation distribution, relative strength index, as well as the relationship between the value at risk and day typical price , to decide if Agenus Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Agenus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (4.67) | Five Day Return 4.79 | Year To Date Return (5.26) | Ten Year Return (94.90) | All Time Return (99.96) |
Last Split Factor 1:20 | Last Split Date 2024-04-12 |
1 | Acquisition by Garo Armen of 4316 shares of Agenus at 3.79 subject to Rule 16b-3 | 12/12/2025 |
2 | Will Agenus Inc. stock benefit from Fed rate cuts - Earnings Overview Summary Low Risk High Win Rate Stock Picks - DonanmHaber | 12/19/2025 |
3 | Acquisition by Garo Armen of 4942 shares of Agenus at 3.31 subject to Rule 16b-3 | 12/26/2025 |
4 | Acquisition by Wright Timothy of 2040 shares of Agenus subject to Rule 16b-3 | 01/02/2026 |
5 | Agenus Q4 2024 Earnings Call Transcript | 01/05/2026 |
6 | Insider Trading | 01/08/2026 |
7 | Acquisition by Garo Armen of 3780 shares of Agenus at 3.91 subject to Rule 16b-3 | 01/09/2026 |
8 | Agenus Upgraded to Buy What Does It Mean for the Stock | 01/13/2026 |
9 | Agenus Announces Closing of 141M Strategic Collaboration with Zydus Lifesciences to Advance BOTBAL and Strengthen U.S. Manufacturing Readiness | 01/15/2026 |
10 | Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab | 01/21/2026 |
11 | Acquisition by Garo Armen of 4562 shares of Agenus at 3.24 subject to Rule 16b-3 | 01/23/2026 |
12 | Agenus Q2 2025 Earnings Call Transcript | 01/27/2026 |
13 | Aug Sentiment Why is Agenus Inc stock going down - Quarterly Trade Summary Community Supported Trade Ideas - baoquankhu1.vn | 02/02/2026 |
14 | Acquisition by Garo Armen of 5027 shares of Agenus at 2.94 subject to Rule 16b-3 | 02/06/2026 |
15 | Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOTBAL in Immunologically Cold Tumors | 02/09/2026 |
| Begin Period Cash Flow | 79.8 M | |
| Total Cashflows From Investing Activities | 27 K |
Agenus Relative Risk vs. Return Landscape
If you would invest 429.00 in Agenus Inc on November 24, 2025 and sell it today you would lose (123.00) from holding Agenus Inc or give up 28.67% of portfolio value over 90 days. Agenus Inc is currently does not generate positive expected returns and assumes 4.764% risk (volatility on return distribution) over the 90 days horizon. In different words, 42% of stocks are less volatile than Agenus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Agenus Target Price Odds to finish over Current Price
The tendency of Agenus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.06 | 90 days | 3.06 | about 83.24 |
Based on a normal probability distribution, the odds of Agenus to move above the current price in 90 days from now is about 83.24 (This Agenus Inc probability density function shows the probability of Agenus Stock to fall within a particular range of prices over 90 days) .
Agenus Price Density |
| Price |
Predictive Modules for Agenus
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Agenus Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Agenus' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Agenus Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Agenus is not an exception. The market had few large corrections towards the Agenus' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Agenus Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Agenus within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.48 | |
β | Beta against Dow Jones | 0.73 | |
σ | Overall volatility | 0.55 | |
Ir | Information ratio | -0.11 |
Agenus Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Agenus for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Agenus Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Agenus Inc generated a negative expected return over the last 90 days | |
| Agenus Inc has high historical volatility and very poor performance | |
| Agenus Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 103.46 M. Net Loss for the year was (232.27 M) with profit before overhead, payroll, taxes, and interest of 87 K. | |
| Agenus Inc currently holds about 218.23 M in cash with (158.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72. | |
| Agenus Inc has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs |
Agenus Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Agenus Stock often depends not only on the future outlook of the current and potential Agenus' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Agenus' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.5 M | |
| Cash And Short Term Investments | 40.4 M |
Agenus Fundamentals Growth
Agenus Stock prices reflect investors' perceptions of the future prospects and financial health of Agenus, and Agenus fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Agenus Stock performance.
| Return On Equity | -12.79 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.33) % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 147.85 M | ||||
| Shares Outstanding | 36.14 M | ||||
| Price To Earning | 10.52 X | ||||
| Price To Book | 218.61 X | ||||
| Price To Sales | 1.04 X | ||||
| Revenue | 103.46 M | ||||
| Gross Profit | 87 K | ||||
| EBITDA | (101.3 M) | ||||
| Net Income | (232.27 M) | ||||
| Cash And Equivalents | 218.23 M | ||||
| Cash Per Share | 0.72 X | ||||
| Total Debt | 94.87 M | ||||
| Debt To Equity | 5.88 % | ||||
| Current Ratio | 1.45 X | ||||
| Book Value Per Share | (8.35) X | ||||
| Cash Flow From Operations | (158.31 M) | ||||
| Earnings Per Share | (1.57) X | ||||
| Market Capitalization | 110.59 M | ||||
| Total Asset | 226.27 M | ||||
| Retained Earnings | (2.18 B) | ||||
| Working Capital | (175.83 M) | ||||
| Current Asset | 63.4 M | ||||
| Current Liabilities | 9.97 M | ||||
About Agenus Performance
By examining Agenus' fundamental ratios, stakeholders can obtain critical insights into Agenus' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Agenus is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 29.43 | 27.96 | |
| Return On Tangible Assets | (1.31) | (1.38) | |
| Return On Capital Employed | (28.45) | (27.03) | |
| Return On Assets | (1.15) | (1.21) | |
| Return On Equity | 0.63 | 0.61 |
Things to note about Agenus Inc performance evaluation
Checking the ongoing alerts about Agenus for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Agenus Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Agenus Inc generated a negative expected return over the last 90 days | |
| Agenus Inc has high historical volatility and very poor performance | |
| Agenus Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 103.46 M. Net Loss for the year was (232.27 M) with profit before overhead, payroll, taxes, and interest of 87 K. | |
| Agenus Inc currently holds about 218.23 M in cash with (158.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72. | |
| Agenus Inc has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs |
- Analyzing Agenus' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Agenus' stock is overvalued or undervalued compared to its peers.
- Examining Agenus' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Agenus' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Agenus' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Agenus' stock. These opinions can provide insight into Agenus' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Will Biotechnology sector continue expanding? Could Agenus diversify its offerings? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Agenus data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.57) | Revenue Per Share | Quarterly Revenue Growth 0.204 | Return On Assets | Return On Equity |
Investors evaluate Agenus Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Agenus' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Agenus' market price to deviate significantly from intrinsic value.
Understanding that Agenus' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Agenus represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Agenus' market price signifies the transaction level at which participants voluntarily complete trades.